SCHEMBL17033

SCHEMBL17033

Nc1ccc(S(=O)(=O)N2CCN[C@](CN3C4COCC3CC(O)C4)(c3ncc(C(O)(C(F)(F)F)C(F)(F)F)cn3)C2)cn1

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 18/20 0.46
GCKR Q14397 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16349 0.92 GCK (0.38) GCKGCKR
SCHEMBL16652 0.84 GCK (0.37) GCKGCKR
SCHEMBL16486 0.83 GCK (0.30) GCK
SCHEMBL21749 0.82 RORC (0.39) GCKGCKR
SCHEMBL17222 0.79 GCK (0.47) GCKGCKR
SCHEMBL16348 0.79
SCHEMBL16613 0.78 GCK (0.47) GCKGCKR
SCHEMBL17217 0.77 GCK (0.46) GCKGCKR
SCHEMBL16804 0.77 GCKR (0.59) GCKGCKR
SCHEMBL23255 0.77 GCK (0.46) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed